B7-33

£15.99£22.74

B7-33 has powerful anti-fibrotic properties. Chronic and acute diseases like heart failure, inflammation of the lungs or the kidneys can all be helped by reducing fibrosis. B7-33 has been shown in animal studies to minimise fibrosis resulting in prolonged survival following injury and providing the treatment for heart failure.

Buy 10 and get 10% Discount
- +

486 in stock

Description

Buy B7-33 2mg  {name}

This product is intended for research and medical purposes only, to be only used by trained professionals.

H2-relaxin, a more significant naturally occurring protein, is the source of B7-33, a soluble single-chain peptide. B7-33 keeps relaxin’s anti-fibrotic properties due to it not increasing cAMP.

B7-33 has powerful anti-fibrotic properties. Chronic and acute diseases like heart failure, inflammation of the lungs or the kidneys can all be helped by reducing fibrosis. Peptide B7-33 has been shown in animal studies to minimise fibrosis resulting in prolonged survival following injury and providing the treatment for heart failure.

In addition, this peptide stimulates ERK1/2 phosphorylation, which promotes MMP2 expression and collagen degradation.

In the event of a cardiac injury, it appears to lessen the amount of scar tissue that forms. Furthermore, the treatment of vascular disorders and preeclampsia of pregnancy have also shown promising results.

Peptides like B7-33 are synthesised from the human H2-relaxin protein.
In addition, relaxin, insulin-like peptide 3, and insulin-like peptide 5 — are all derivatives of the human H2-relaxin protein. Insulin-like peptides, such as these, have affected the cardiovascular, musculoskeletal, and reproductive systems and others.

Four endogenous receptors (RXFP1/2 and RXFP3/4) exist for the relaxin family peptides. These receptors’ functions are outlined in the following manner:

  • RXFP-1: Essential role in sperm motility, pregnancy, vascular endothelial cells, and joint health.
  • RXFP-2: Plays a vital role in the development of the testis.
  • RXFP-3 mutations linked to Schizotypal personality disorder and specific sleep problems.
  • RXFP-4: has been demonstrated that insulin-like peptide 5 plays a role in hunger/satiation signalling and is expressed on sperm.

However, relaxin proteins are not the only ones that can bind to the receptors of the relaxin system. GLP-1 and several insulin-like peptides, as well as cAMP and orexin, can all stimulate these receptors.

Anti-inflammatory, antioxidant, and wound healing properties have all been demonstrated for agonists. Relaxin was found to be the primary ligand for these receptors after these findings.

Researchers have discovered that relaxin dilates blood vessels, stimulates blood vessel growth, and acts as antihypertrophic. Because of its anti-fibrotic properties, relaxin and its derivatives have been the subject of extensive research to treat acute heart failure and other fibrotic diseases.


References:

  1. https://pubmed.ncbi.nlm.nih.gov/32295457/
  2. https://pubs.acs.org/doi/abs/10.1021/acsami.9b17859

Sequence: VIKLSGRELVRAQIAISGMSTWSKRSL

Storage: Lyophilized peptides stored below -18°C.

Research use only. Not for human or animal consumption!


Disclaimer: We do not supply peptides to Any individual under the age of 18. You must be a licensed and qualified healthcare practitioner. Our team of dedicated professionals are committed to providing an extensive range of products used ONLY FOR medical research by responsible trained and professional individuals. All products listed on this website (https://direct-peptides.com) and provided through Direct Peptides are intended for medical research purposes only. Direct Peptides does not encourage or promote the use of any of these products in a personal capacity (i.e. human consumption), nor are the products intended as a drug, stimulant or for use in any food products.